LGC Limited, Queens Road, Teddington, Middlesex, TW11 0LY, UK.
BMC Genomics. 2011 Feb 18;12:118. doi: 10.1186/1471-2164-12-118.
The availability of diverse RT-qPCR assay formats and technologies hinder comparability of data between platforms. Reference standards to facilitate platform evaluation and comparability are needed. We have explored using universal RNA standards for comparing the performance of a novel qPCR platform (Fluidigm® BioMark™) against the widely used ABI 7900HT system. Our results show that such standards may form part of a toolkit to evaluate the key performance characteristics of platforms.
不同的 RT-qPCR 分析方法和技术的可用性阻碍了平台间数据的可比性。需要参考标准来促进平台评估和可比性。我们已经探讨了使用通用 RNA 标准来比较新型 qPCR 平台(Fluidigm® BioMark™)与广泛使用的 ABI 7900HT 系统的性能。我们的结果表明,此类标准可以成为评估平台关键性能特征的工具包的一部分。